Mathieu Repellin

Check out our recently published article on nanomedicine for treating skeletal muscle in myotonic dystrophy type 1! Very proud of this instructive collaborative work through @UniVerona @iNeuroMyoGene @ISPB_Lyon1
sciencedirect.com/science/articl…

Really glad to have participated to the excellent ESCDD2022 congress. Really nice occasion to share my work on RNA-Lipid nanoparticles for muscular dystrophies treatment during the poster session!
#ESCDD #EgmondAanZee #LAGEPP